Jim Simons Argenx Se Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$356.95 - $413.29 $428,340 - $495,948	1,200 New	1,200 $472,000
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $3.43 Million - $5.1 Million	-9,300 Reduced 8.16%	104,700 $51.5 Million
Q2 2023 Aug 11, 2023	BUY	$360.14 - $422.58 $5.19 Million - $6.09 Million	14,400 Added 14.46%	114,000 $44.4 Million
Q1 2023 May 12, 2023	BUY	$334.23 - $403.65 $5.18 Million - $6.26 Million	15,500 Added 18.43%	99,600 $37.1 Million
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $25.1 Million - $29.6 Million	73,500 Added 693.4%	84,100 $31.9 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $3.64 Million - $4.19 Million	10,600 New	10,600 $3.74 Million
Q4 2021 Feb 11, 2022	SELL	$272.01 - $353.03 $9.76 Million - $12.7 Million	-35,874 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $1.85 Million - $2.2 Million	6,274 Added 21.2%	35,874 $10.8 Million
Q2 2021 Aug 13, 2021	SELL	$257.11 - $319.92 $802,697 - $998,790	-3,122 Reduced 9.54%	29,600 $8.91 Million
Q1 2021 May 13, 2021	SELL	$268.3 - $380.31 $9.65 Million - $13.7 Million	-35,978 Reduced 52.37%	32,722 $9.01 Million
Q4 2020 Feb 10, 2021	SELL	$248.13 - $308.36 $6.5 Million - $8.08 Million	-26,200 Reduced 27.61%	68,700 $20.2 Million
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $7.57 Million - $9.57 Million	-35,114 Reduced 27.01%	94,900 $24.9 Million
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $10 Million - $18.3 Million	78,641 Added 153.08%	130,014 $29.3 Million
Q1 2020 May 14, 2020	BUY	$108.83 - $165.23 $2.86 Million - $4.34 Million	26,282 Added 104.75%	51,373 $6.77 Million
Q4 2019 Feb 13, 2020	SELL	$106.59 - $164.21 $43,595 - $67,161	-409 Reduced 1.6%	25,091 $4.03 Million
Q3 2019 Nov 13, 2019	SELL	$113.31 - $150.51 $6.45 Million - $8.56 Million	-56,900 Reduced 69.05%	25,500 $2.91 Million
Q2 2019 Aug 12, 2019	BUY	$115.0 - $141.58 $4.52 Million - $5.56 Million	39,300 Added 91.18%	82,400 $11.7 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $4.26 Million - $5.8 Million	43,100 New	43,100 $5.38 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.66 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$778 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account